Article
27 Mar 2026
CJEU Rules On GDPR Access Rights And Abuse Of Rights: What The Brillen Rottler Judgment Means For Life Sciences Companies
AUTHORS CONTENT
Article
23 Mar 2026
EDPB/EDPS Joint Opinion On The European Biotech Act Proposal: Key Data Protection Implications For Pharma And Life Sciences
Article
17 Mar 2026
Provisional Text Of The Political Agreement On The Reform To The EU Regulatory Framework For Medicinal Products Is Published
Article
16 Mar 2026
Advancing AI Adoption In Manufacturing Under The Existing FDA & EMA Frameworks
Article
09 Mar 2026
Virtual And Digital Health Digest – February 2026
Article
06 Mar 2026
EU Digital Omnibus: What The Proposed Reforms Mean For Pharma And MedTech
Article
10 Feb 2026
UK's Data (Use And Access) Act: What Life Sciences Companies Need To Know
Article
03 Feb 2026
Virtual And Digital Health Digest – December 2025
Article
30 Jan 2026
Virtual And Digital Health Digest - January 2026
Article
24 Dec 2025
From Complexity To Clarity: How The EU Commission Plans To Overhaul The MDR And IVDR
Article
17 Dec 2025
European Institutions Agree On The Reform To The EU Regulatory Framework For Medicinal Products
Article
11 Dec 2025
Virtual And Digital Health Digest – November 2025
Article
05 Dec 2025
Virtual And Digital Health Digest
Article
04 Dec 2025
New Medical Device And IVD Registration And Transparency Requirements To Apply In 2026
Article
01 Dec 2025
Can A Chemically Synthesised Medicine Be Authorised As A Generic Of A Biological Medicine? And Who Can Challenge This?
Article
01 Dec 2025
Digital Omnibus: The European Commission Published Its Proposal To Amend The GDPR, AI Act, Data Act And Other Related Frameworks
Article
28 Nov 2025
Virtual And Digital Health Digest (October/November 2025)
Article
03 Nov 2025
Virtual And Digital Health Digest – October 2025
Article
26 Sep 2025
European Commission Publishes New Variation Guidelines For Medicines
Article
08 Sep 2025
CJEU Clarifies The Concept Of Pseudonymised Data
AWARDS
